{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T05:28:07Z","timestamp":1676784487667},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.cpet.2008.08.007","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T10:49:24Z","timestamp":1228646964000},"page":"197-205","source":"Crossref","is-referenced-by-count":2,"title":["PET\/CT in Neuroendocrine Tumors"],"prefix":"10.1016","volume":"3","author":[{"given":"Paolo","family":"Castellucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Montini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cpet.2008.08.007_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2008.08.007_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cpet.2008.08.007_bib3","series-title":"Neuroendocrine tumors: a comprehensive guide to diagnosis and management","author":"Vinik","year":"2006"},{"key":"10.1016\/j.cpet.2008.08.007_bib4","series-title":"International histological classification of tumors in collaboration with 9 pathologists from 4 countries","article-title":"Histological typing of tumors","author":"Solcia","year":"2000"},{"key":"10.1016\/j.cpet.2008.08.007_bib5","series-title":"Harrison's principles of internal medicine","article-title":"Endocrine tumors of the gastrointestinal tract and pancreas","author":"Jensen","year":"2005"},{"key":"10.1016\/j.cpet.2008.08.007_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cpet.2008.08.007_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cpet.2008.08.007_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2008.08.007_bib11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labeled DOTA-conjugated somatostatin analogues superior to those labeled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","article-title":"Imaging of neuroendocrine tumors","volume":"36","author":"Rufini","year":"2006","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J\u00a0Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib15","volume":"vol 4","author":"R\u00f6sch","year":"2003"},{"key":"10.1016\/j.cpet.2008.08.007_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","article-title":"Processing of generator-produced 68Ga for medical application","volume":"48","author":"Zhernosekov","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib17","first-page":"68","article-title":"Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies","volume":"44","author":"Eriksson","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib18","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.1998.16.7.2534","article-title":"Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors","volume":"16","author":"Orlefors","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpet.2008.08.007_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mds.870050304","article-title":"The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies","volume":"5","author":"Eidelberg","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/j.cpet.2008.08.007_bib20","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00259-007-0498-y","article-title":"The added value of [(18)F]fluoro-L: -DOPA PET in\u00a0the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children","volume":"34","author":"Ribeiro","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","article-title":"Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors","volume":"220","author":"Hoegerle","year":"2001","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cpet.2008.08.007_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-007-0587-y","article-title":"(68)Ga-DOTA-NOC: biodistribution and dosimetry in patients affected by neuroendocrine tomors","volume":"35","author":"Pettinato","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1470-2045(06)70801-4","article-title":"Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study","volume":"7","author":"Koopmans","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cpet.2008.08.007_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.107.042721","article-title":"The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma","volume":"48","author":"Timmers","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib26","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","article-title":"Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data","volume":"28","author":"Hofmann","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","article-title":"Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors","volume":"5","author":"Kowalski","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.cpet.2008.08.007_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-008-0769-2","article-title":"Castellucci P comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuroendocrine tumours","author":"Ambrosini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib29","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET","volume":"45","author":"Becherer","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","article-title":"Pheochromocytomas: detection with 18F DOPA whole body PET\u2013initial results","volume":"222","author":"Hoegerle","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2008.08.007_bib31","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2967\/jnumed.107.041947","article-title":"18F-DOPA PET and PET\/CT","volume":"48","author":"Nanni","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00259-007-0425-2","article-title":"Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma","volume":"34","author":"Beuthien-Baumann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2008.08.007_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MNM.0b013e328182d606","article-title":"Role of 18F-dopa PET\/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours","volume":"28","author":"Ambrosini","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.cpet.2008.08.007_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-07-0369","article-title":"The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma","volume":"157","author":"Mackenzie","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpet.2008.08.007_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s002689900439","article-title":"Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior?","volume":"22","author":"Pasquali","year":"1998","journal-title":"World J\u00a0Surg"},{"key":"10.1016\/j.cpet.2008.08.007_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.rlu.0000109329.34975.9f","article-title":"Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors","volume":"29","author":"Scanga","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1196\/annals.1294.027","article-title":"PET in the diagnosis of neuroendocrine tumors","volume":"1014","author":"Sundin","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cpet.2008.08.007_bib39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/snuc.2002.126052","article-title":"18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer","volume":"32","author":"Zhao","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000109605","article-title":"Functional imaging of the pancreas: the role of 18F-DOPA PET in the diagnosis of hyperinsulinism of infancy","volume":"12","author":"Ribeiro","year":"2007","journal-title":"Endocr Dev"},{"issue":"3","key":"10.1016\/j.cpet.2008.08.007_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2007-2036","article-title":"Mau H evaluation of 18FDOPA PET\/CT for surgery in focal congenital hyperinsulinism","volume":"93","author":"Barthlen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpet.2008.08.007_bib42","first-page":"16","article-title":"PET hydroxyephedrine imaging of neuroblastoma","volume":"37","author":"Shulkin","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib43","first-page":"1125","article-title":"PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2008.08.007_bib44","first-page":"1635","article-title":"Whole body PET\/CT with 11C HED in tumors of the sympatetic nervous system: feasibility study and comparison with 123I MIBG SPECT \/CT","volume":"47","author":"Franzius","year":"2006","journal-title":"J Nuc Med"},{"key":"10.1016\/j.cpet.2008.08.007_bib45","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.1995.13.8.2094","article-title":"Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin","volume":"13","author":"Abbruzzese","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpet.2008.08.007_bib46","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.148.9.2035","article-title":"Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients","volume":"148","author":"Le Chevalier","year":"1988","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.cpet.2008.08.007_bib47","first-page":"375","article-title":"Receptor radionuclide therapy of tumors: a road from basic research to clinical application","volume":"47","author":"Bodei","year":"2006","journal-title":"J Nuc Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859808000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859808000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T20:58:02Z","timestamp":1545598682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859808000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1556859808000655"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2008.08.007","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}